Clinical Trial Update: NMDA Enhancement Combined With Omega-3 for Early Dementia [Phase 2]

View source ↗

Summary

A Phase 2 trial is planned to test NMDA receptor enhancement in combination with omega-3 fatty acids for early dementia, and the study is currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• NMDA receptor modulator (experimental)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Omega 3 Fatty Acids, Dementia | Phase 2 | Status: NOT_YET_RECRUITING